Wall Street analysts forecast that Biogen Inc. (BIIB) will report quarterly earnings of $3.94 per share in its upcoming release, pointing to a year-over-year decline of 25.4%. It is anticipated that revenues will amount to $2.32 billion, exhibiting a decrease of 5.8% compared to the year-ago quarter.Over the last 30 days, there has been a downward revision of 2.7% in the consensus EPS estimate for the quarter, leading to its current level. This signifies the covering analysts' collective reconsideration of ...